Application of the Original L-Ornithine-L-Aspartate in Patients with Complex Cardiovascular Disease and Type 2 Diabetes Mellitus

Application of the Original L-Ornithine-L-Aspartate in Patients with Complex Cardiovascular Disease and Type 2 Diabetes Mellitus

The article deals with the treatment of nonalcoholic fatty liver disease as a complication in patients with complex cardiovascular disease and type 2 diabetes mellitus. The data from the studies on the effect of Hepa-Merz® on the functional state of the liver, endothelium, blood rheology, the state...

Full description

Bibliographic Details
Main Authors: V.Yu. Zharynova, K.N. Ihrunova, L.A. Bodretska, V.P. Chyzhova, I.A. Samots, Zh.S. Butynets, A.Yu. Haletskyi, N.N. Benkovska, V.O. Tabakovych-Vatseba
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2015-11-01
Series:Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:
diabetes mellitus
cardiovascular disease
hepatoprotectors
non-alcoholic fatty liver disease
Online Access:http://iej.zaslavsky.com.ua/article/view/72335

Internet

http://iej.zaslavsky.com.ua/article/view/72335

Similar Items